Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion type Assertion NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_head.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in gallbladder cancer]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_provenance.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion evidence source_evidence_literature NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_provenance.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion SIO_000772 18692501 NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_provenance.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion wasDerivedFrom lhgdn-20090331 NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_provenance.
- NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_assertion wasGeneratedBy ECO_0000203 NP208950.RAX2uZVMTVn1kwoFYNX5NxePIsKl9UqmvyTp16-AP1svw130_provenance.